Yang Y - Search Results

1

Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China.

Yang Y, Chen K, Zhou Y, Hu Z, Chen S, Huang Y. Yang Y, et al. Onco Targets Ther. 2018 Jan 30;11:587-597. doi: 10.2147/OTT.S152957. eCollection 2018. Onco Targets Ther. 2018. PMID: 29430184 Free PMC article.

2

Single-incision versus conventional three-port video-assisted surgery in the treatment of pneumothorax: a systematic review and meta-analysis.

Yang Y, Dong J, Huang Y. Yang Y, et al. Interact Cardiovasc Thorac Surg. 2016 Nov;23(5):722-728. doi: 10.1093/icvts/ivw217. Epub 2016 Jul 21. Interact Cardiovasc Thorac Surg. 2016. PMID: 27444651 Review.

3

Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China.

Zhou Y, Yang Y, Yang C, Chen Y, Yang C, Du Y, Zhao G, Guo Y, Ye L, Huang Y. Zhou Y, et al. Among authors: yang c, yang y. Oncotarget. 2017 Feb 28;8(9):15023-15033. doi: 10.18632/oncotarget.14706. Oncotarget. 2017. PMID: 28107191 Free PMC article.

4

The prognostic value of cyclooxygenase-2 expression in patients with esophageal cancer: evidence from a meta-analysis.

Hu Z, Yang Y, Zhao Y, Huang Y. Hu Z, et al. Among authors: yang y. Onco Targets Ther. 2017 Jun 9;10:2893-2901. doi: 10.2147/OTT.S134599. eCollection 2017. Onco Targets Ther. 2017. PMID: 28652771 Free PMC article. Review.

5

The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers.

Yang Y, Hu Z, Zhou Y, Zhao G, Lei Y, Li G, Chen S, Chen K, Shen Z, Chen X, Dai P, Huang Y. Yang Y, et al. Oncotarget. 2017 Oct 4;8(52):90197-90214. doi: 10.18632/oncotarget.21644. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163821 Free PMC article.

6

MicroRNA expression profiling of lung adenocarcinoma in Xuanwei, China: A preliminary study.

Hu Z, Wang X, Yang Y, Zhao Y, Shen Z, Huang Y. Hu Z, et al. Among authors: yang y. Medicine (Baltimore). 2019 May;98(21):e15717. doi: 10.1097/MD.0000000000015717. Medicine (Baltimore). 2019. PMID: 31124951 Free PMC article.

7

CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma.

Yang Y, Hu Z, Sun H, Yu Q, Yang L, Yin F, Sun Y, Pu L, Zhu X, Li S, Chen X, Zhao Y. Yang Y, et al. Among authors: yang l. Onco Targets Ther. 2021 Dec 24;14:5477-5492. doi: 10.2147/OTT.S325203. eCollection 2021. Onco Targets Ther. 2021. PMID: 34992383 Free PMC article.

8

Linc00996 is a favorable prognostic factor in LUAD: Results from bioinformatics analysis and experimental validation.

Shen Z, Li X, Hu Z, Yang Y, Yang Z, Li S, Zhou Y, Ma J, Li H, Liu X, Cai J, Pu L, Wang X, Huang Y. Shen Z, et al. Among authors: yang y, yang z. Front Genet. 2022 Sep 2;13:932973. doi: 10.3389/fgene.2022.932973. eCollection 2022. Front Genet. 2022. PMID: 36118847 Free PMC article.

9

Pan-cancer landscape of CENPO and its underlying mechanism in LUAD.

Shi T, Hu Z, Tian L, Yang Y. Shi T, et al. Among authors: yang y. Respir Res. 2023 Apr 15;24(1):113. doi: 10.1186/s12931-023-02408-3. Respir Res. 2023. PMID: 37061713 Free PMC article.

10

Advances in lung adenocarcinoma: A novel perspective on prognoses and immune responses of CENPO as an oncogenic superenhancer.

Shi T, Hu Z, Tian L, Yang Y. Shi T, et al. Among authors: yang y. Transl Oncol. 2023 Aug;34:101691. doi: 10.1016/j.tranon.2023.101691. Epub 2023 May 17. Transl Oncol. 2023. PMID: 37207381 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109,913 results

Search Page

Filters